These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7691862)

  • 61. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
    Kwekkeboom DJ; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomas.
    Hanson PL; Aylwin SJ; Monson JP; Burrin JM
    Eur J Endocrinol; 2005 Mar; 152(3):363-70. PubMed ID: 15757852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
    Harris RI; Schatz NJ; Gennarelli T; Savino PJ; Cobbs WH; Snyder PJ
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.
    Klibanski A; Deutsch PJ; Jameson JL; Ridgway EC; Crowley WF; Hsu DW; Habener JF; Black PM
    J Clin Endocrinol Metab; 1987 Mar; 64(3):536-42. PubMed ID: 3102541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunodetection of chorionic gonadotropin and its subunits in human nonfunctioning pituitary adenomas.
    Saccomanno K; Spada A; Bassetti M; Gil-del-Alamo P; Faglia G
    J Clin Endocrinol Metab; 1994 May; 78(5):1103-7. PubMed ID: 7513714
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.
    Damjanović SS; Popović VP; Petakov MS; Nikolic-Durović MM; Doknić MZ; Gligorović MS
    J Endocrinol Invest; 1996 Nov; 19(10):663-9. PubMed ID: 9007697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
    Chanson P; Lahlou N; Warnet A; Roger M; Sassolas G; Lubetzi J; Schaison G; Bouchard P
    J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas.
    Andersen M; Bjerre P; Schrøder HD; Edal A; Høilund-Carlsen PF; Pedersen PH; Hagen C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):23-30. PubMed ID: 11167922
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Secretion of LH, FSH, and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas.
    Mashiter K; Adams E; Van Noorden S
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):103-12. PubMed ID: 6796297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined beta FSH and beta LH response to TRH in patients with clinically non-functioning pituitary adenomas.
    Somjen D; Tordjman K; Kohen F; Baz M; Razon N; Ouaknine G; Stern N
    Clin Endocrinol (Oxf); 1997 May; 46(5):555-62. PubMed ID: 9231051
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release.
    Medri G; Carella C; Padmanabhan V; Rossi CM; Amato G; De Santo NG; Beitins IZ; Beck-Peccoz P
    J Endocrinol Invest; 1993 Mar; 16(3):169-74. PubMed ID: 7685785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Luteinizing hormone (LH) and prolactin-releasing pituitary tumor: possible malignant transformation of the LH cell line.
    Spertini F; Deruaz JP; Perentes E; Pelet B; Gomez F
    J Clin Endocrinol Metab; 1986 May; 62(5):849-54. PubMed ID: 3514650
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Secretion of polypeptide growth factors by human nonfunctioning pituitary adenoma cells in culture.
    Renner U; Mojto J; Arzt E; Lange M; Stalla J; Müller OA; Stalla GK
    Neuroendocrinology; 1993 May; 57(5):825-34. PubMed ID: 8413819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
    Aylwin SJ; Welch JP; Davey CL; Geddes JF; Wood DF; Besser GM; Grossman AB; Monson JP; Burrin JM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2476-83. PubMed ID: 11397843
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Central hypogonadism due to a giant, "silent" FSH-secreting, atypical pituitary adenoma: effects of adenoma dissection and short-term Leydig cell stimulation by luteinizing hormone (LH) and human chorionic gonadotropin (hCG).
    Santi D; Spaggiari G; Casarini L; Fanelli F; Mezzullo M; Pagotto U; Granata ARM; Carani C; Simoni M
    Aging Male; 2017 Jun; 20(2):96-101. PubMed ID: 28067604
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomas.
    Kwekkeboom DJ; de Jong FH; Lamberts SW
    J Steroid Biochem; 1989 Oct; 33(4B):777-82. PubMed ID: 2513452
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential regulation of gonadotropins and glycoprotein hormone alpha-subunit by IGF-I in anterior pituitary cells from male rats.
    Pazos F; Sánchez-Franco F; Balsa J; Escalada J; Cacicedo L
    J Endocrinol Invest; 2004; 27(7):670-5. PubMed ID: 15505992
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
    Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
    Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
    Astaf'eva LI; Kadashev BA; Shishkina LV; Kalinin PL; Fomichev DV; Kutin MA; Aref'eva IA; Dzeranova LK; Sidneva YG; Klochkova IS; Rotin DL
    Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(6):24-35. PubMed ID: 28139570
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro.
    van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; Mol JA
    Eur J Endocrinol; 1998 Mar; 138(3):309-15. PubMed ID: 9539306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.